VERA Vera Therapeutics Inc
Company Analysis
Latest News
🔴 Vera Therapeutics is trading 4.38% down today as crude oil and Treasury yields pressure stocks
Vera Therapeutics is trading 4.38% lower at $34.67 as rising crude oil and Treasury yields weigh on equity valuations. - The Nasdaq Composite is down 1.16% and...
🟢 Vera Therapeutics is trading 4.42% up today; move remains unattributed
Vera Therapeutics is trading 4.42% up at $35.77, with today’s move unattributed. - On September 15, TRUTAKNA met all prespecified ORIGIN 3 endpoints. - Vera...
🟢 Vera Therapeutics is trading 10.3% up today as biotech stocks rally broadly
Vera Therapeutics is trading 10.26% up now at $35.03 as biotechnology stocks rally broadly, with XBI up 2.55% and the Nasdaq Composite up 1.41%. - The move...
🟢 Vera Therapeutics is trading 7% up today as biotech stocks rally
Vera Therapeutics is trading at $34.27 (+7.00%), driven by biotech-sector strength. - The XBI ETF is up 2.55%, supporting sector-wide gains, while the Nasdaq...
🔴 Vera Therapeutics is trading 4.04% down today despite positive TRUTAKNA Phase 3 results
Vera Therapeutics is trading 4.04% down at $32.31 after reversing gains from September 15’s positive TRUTAKNA Phase 3 results. - The ORIGIN 3 study met all...
🟢 Vera Therapeutics is trading 4.46% up today after TRUTAKNA met all Phase 3 endpoints
Vera Therapeutics is trading at $35.57 (+4.46%) after TRUTAKNA met all prespecified endpoints in the final ORIGIN 3 Phase 3 analysis for IgA nephropathy. -...
Vera Therapeutics Reports Positive Final Phase 3 Trial Results for TRUTAKNA in IgAN
Vera Therapeutics announced that its drug, TRUTAKNA™ (atacicept-vymj), met all prespecified endpoints in the final efficacy analysis of the ORIGIN 3 trial for...
🔴 Vera Therapeutics is trading 4.47% down today as major U.S. indexes fall
Vera Therapeutics is trading 4.47% down now at $33.48, with the decline appearing primarily aligned with broader risk-off sentiment. - No clear...
🟢 Vera Therapeutics is trading 5% up today after inflation data matched expectations
Vera Therapeutics is trading at $35.20, up +4.76% on September 11, 2026, alongside broad market gains after August inflation data matched expectations. - The...
🔴 Vera Therapeutics is trading 4.25% down today as U.S. equities declined
Vera Therapeutics is trading 4.25% down at $33.78 as broad risk-off pressure weighed on U.S. equities on September 9, 2026. - No clear company-specific...
🔴 Vera Therapeutics is trading 4.07% down today with no company-specific catalyst identified
Vera Therapeutics is trading at $35.32 (-4.07%) with no new company-specific announcement identified for August 27, 2026. - Recent gains followed 4.37%,...
🟢 Vera Therapeutics is trading 4.13% up today on biotech-sector strength
Vera Therapeutics is trading at $36.74, up +4.13%, primarily on biotech-sector strength. - No new company-specific announcement was identified for August 26,...
🟢 Vera Therapeutics is trading 4.9% up today on biotech-sector strength
Vera Therapeutics is trading 4.9% up now at $35.35, supported by biotechnology strength and gains in major U.S. indexes. - No new company-specific catalyst...
🟢 Vera Therapeutics is trading 7.14% up today
Vera Therapeutics is trading 7.14% up at $34.53, but no catalyst has been confidently identified. - No company-specific announcement, filing, analyst action,...
🟢 Vera Therapeutics is trading 4.06% up today amid a broader biotech rally
Vera Therapeutics is trading 4.06% up now at $32.53 as biotechnology shares continue recovering after recent sector volatility. - No new company-specific...
🔴 Vera Therapeutics falls 4.3% — Biotech Sector Cools Off After Moderna-Sparked Rally
With Biotech (XBI) down 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a pullback after a...
Vera's FDA Review Win Sends Shares Surging — But Can a $425,000 Drug Survive a Crowded Kidney Market?
Shares jumped 10.3% to $31.86 after the FDA published an integrated review describing a favorable safety-and-efficacy profile for Vera Therapeutics' recently...
🟢 Vera Therapeutics is trading 10% up today after FDA review signals Trutakna’s competitive profile
Vera Therapeutics is trading 10.28% up now at $31.86 after the FDA published an integrated review describing a favorable profile for Trutakna, its recently...
🟢 Vera Therapeutics surges 10% after FDA publishes favorable review of Trutakna and investors reassess Q2 results
Vera Therapeutics (VERA) stock is trading 9.93% up at $31.76 today. - The surge follows the FDA's publication of a favorable integrated review of Trutakna, its...
🟢 Vera Therapeutics is trading 6% up today in pre-market following stronger August 13 U.S. market performance
Vera Therapeutics is trading at $30.54, up +5.71%, in pre-market on August 14, 2026, likely reflecting broader risk-on sentiment following stronger August 13,...